ADVISORY, Oct. 10, 2013 (GLOBE NEWSWIRE) -- What: MacroGenics, Inc. [MGNX], a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, will visit the NASDAQ MarketSite in Times Square in celebration of its October 10 initial public offering (IPO) on The NASDAQ Stock Market.
Help employers find you! Check out all the jobs and post your resume.
